ZIVO (Zivo Bioscience) Beginning Cash Position: $0.01 Mil (As of Sep. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ZIVO Zivo Bioscience Inc ZIVO
8 GF Score
Price $4.00
! 5 Warning Signs
View Full Analysis

What is Zivo Bioscience Beginning Cash Position?

Zivo Bioscience ZIVO 8 Beginning Cash Position is $0.01 Mil as of Sep. 2025. GuruFocus rates ZIVO with a GF Score™ of 8/100. The stock has 5 warning signs investors should review.

Zivo Bioscience's Beginning Cash Position for the quarter that ended in Sep. 2025 was $0.01 Mil.

Zivo Bioscience's quarterly Beginning Cash Position declined from Mar. 2025 ($1.54 Mil) to Jun. 2025 ($0.52 Mil) and declined from Jun. 2025 ($0.52 Mil) to Sep. 2025 ($0.01 Mil).

Zivo Bioscience's annual Beginning Cash Position declined from Dec. 2022 ($8.90 Mil) to Dec. 2023 ($1.80 Mil) and declined from Dec. 2023 ($1.80 Mil) to Dec. 2024 ($0.27 Mil).

Zivo Bioscience Beginning Cash Position Related Terms

Zivo Bioscience Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Zivo Bioscience's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zivo Bioscience Beginning Cash Position Chart

Zivo Bioscience Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.35 0.14 8.90 1.80 0.27

Zivo Bioscience Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.16 1.54 0.52 0.01
ZIVO
8GF Score
Zivo Bioscience Inc ZIVO
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zivo Bioscience Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $0.01 Mil mean?
Zivo Bioscience (ZIVO) has a Beginning Cash Position of $0.01 Mil as of Sep. 2025. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Zivo Bioscience and its competitors.
Is Zivo Bioscience's Beginning Cash Position too high?
Zivo Bioscience's current Beginning Cash Position is $0.01 Mil. Overall, Zivo Bioscience has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Zivo Bioscience's Beginning Cash Position compare to CVM and HOWL?
Zivo Bioscience's Beginning Cash Position of $0.01 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Biotechnology company?
A good Beginning Cash Position depends on the Biotechnology industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Zivo Bioscience and its competitors. Zivo Bioscience's current Beginning Cash Position is $0.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zivo Bioscience stock overvalued right now?
Zivo Bioscience (ZIVO) has a current Beginning Cash Position of $0.01 Mil. The current Beginning Cash Position is $0.01 Mil. Zivo Bioscience's overall GF Score™ is 8/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Zivo Bioscience (ZIVO), the current Beginning Cash Position is $0.01 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Zivo Bioscience Business Description

Address 2125 Butterfield Drive, Suite 100, Troy, MI, USA, 48084
Zivo Bioscience Inc operates in one reportable segment microalgae technology. The segment is research and development operating in both the therapeutic and nutritional sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. The company's applications are ANIMAL APPLICATIONS, HUMAN APPLICATIONS.
8GF Score

Get the complete analysis for ZIVO

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.00
Price